Earnings Ahead

ZBH - Zimmer Biomet Holdings, Inc.

144.81 2 1.4

  1. Home
  2. Healthcare
  3. ZBH
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

About

Profile

At Zimmer Biomet, we pursue exceptional outcomes. Our innovations help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Alongside some of the world's top healthcare professionals, we help deliver new po

Headquarters

Warsaw, Indiana, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

ZBH



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Zimmer Biomet Non-GAAP EPS of $2.20 beats by $0.04, revenue of $1.94B beats by $10M
  • Zimmer Biomet Q4 2023 Earnings Preview
  • Stryker, Boston Scientific fuel MedTech gains
  • Anti-obesity meds can expand the market for weight loss surgery: Bernstein
  • J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
  • BTIG makes top medtech stock picks for 2024, sees sector stabilizing
  • Zimmer Biomet declares $0.24 dividend
  • Piper sees GLP-1s increasing demand for knee/hip surgeries near-term
  • M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey
  • MedTech stocks gain after Novo Nordisk data for weight loss therapy
  • Zimmer Biomet shares slide 4% amid lowered revenue outlook
  • Zimmer Biomet Non-GAAP EPS of $1.65 beats by $0.05, revenue of $1.75B in-line
  • Zimmer Biomet Q3 2023 Earnings Preview
  • UBS’s top crowded longs and shorts in MedTech
  • Zimmer Biomet gains on “very confident” H2 guidance
  • JPMorgan says time to buy MedTech based on past
  • Zimmer Biomet declares $0.24 dividend
  • 3M grabs Hanson from Zimmer Biomet to lead healthcare spinoff
  • Zimmer Biomet shuffles management as COO takes CEO role; reaffirms FY23 guidance
  • Zimmer Biomet beats Q2 top and bottom line estimates; raises FY23 outlook

Earnings History

Date EPS / Forecast Revenue / Forecast
February 7, 2022 1.95 / 1.98 2.04B / 2.07B
November 4, 2021 1.81 / 1.76 1.92B / 1.94B
August 3, 2021 1.9 / 1.86 2.03B / 1.97B Beat!
May 4, 2021 1.71 / 1.53 1.85B / 1.76B Beat!
February 5, 2021 2.11 / 2.06 2.09B / 2.08B Beat!
November 6, 2020 1.81 / 1.07 1.93B / 1.71B Beat!
August 4, 2020 0.05 / -0.71 1.23B / 921.26M
July 24, 2020 - / -0.08 - / 1.16B
May 11, 2020 1.7 / 1.43 1.78B / 1.82B
February 4, 2020 2.3 / 2.27 2.13B / 2.11B Beat!
November 5, 2019 1.77 / 1.75 1.89B / 1.87B Beat!
July 26, 2019 1.93 / 1.91 1.99B / 1.98B Beat!
April 26, 2019 1.87 / 1.86 1.98B / 1.96B Beat!
February 1, 2019 2.18 / 2.17 2.07B / 2.06B Beat!
October 26, 2018 1.63 / 1.6 1.84B / 1.83B Beat!
July 27, 2018 1.92 / 1.88 2.01B / 1.99B Beat!
April 26, 2018 1.91 / 1.89 2.02B / 1.98B Beat!
Date Price Open High Low Vol Change ER
Mar 4 120.44 120.59
121.16
119.05
1.36M -1.38%
Mar 3 122.13 123.72
123.94
121.18
1.50M -0.46%
Mar 2 122.69 122.54
124.30
121.86
2.07M -1.17%
Mar 1 124.14 124.77
126.46
121.08
7.10M -2.4%
Feb 28 127.19 125.22
127.40
124.96
2.39M 0.39%
 
Feb 25 126.70 124.18
126.81
122.56
1.59M 2.61%
Feb 24 123.48 120.63
123.58
119.82
1.42M 0.73%
Feb 23 122.58 123.49
124.42
121.89
1.42M -0.32%
Feb 22 122.97 121.56
124.35
121.00
2.08M 1.61%
Feb 18 121.02 119.84
121.79
119.84
1.20M 0.88%
Feb 17 119.97 121.93
121.93
119.49
1.26M -2.07%
Feb 16 122.50 121.44
122.68
119.64
1.70M 0.29%
Feb 15 122.14 118.73
122.28
118.39
1.51M 4.40%
Feb 14 116.99 116.59
117.96
115.57
1.11M 0.67%
Feb 11 116.21 119.38
120.47
116.05
1.85M -2.16%
Feb 10 118.77 119.05
121.20
118.30
2.41M -1.07%
Feb 9 120.05 120.33
122.20
119.76
2.14M 0.14%
Feb 8 119.88 108.79
120.32
108.47
4.52M 7.35%
Feb 7 111.67 114.30
118.89
111.53
6.18M -9.09%